Literature DB >> 18170843

CLINICAL EVALUATION OF A NEW MYDRIATIC-MYDRILATE.

E C Cowan, D Archer.   

Abstract

Mesh:

Substances:

Year:  1962        PMID: 18170843      PMCID: PMC510278          DOI: 10.1136/bjo.46.12.730

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  4 in total

1.  Cyclopentolate hydrochloride: A new mydriatic and cycloplegic agent; a pharmacologic and clinical evaluation.

Authors:  D M GORDON; M H EHRENBERG
Journal:  Am J Ophthalmol       Date:  1954-12       Impact factor: 5.258

2.  Three new cycloplegic drugs; clinical report.

Authors:  B C GETTES
Journal:  AMA Arch Ophthalmol       Date:  1954-04

3.  Evaluation of a new cycloplegic.

Authors:  L H EHRLICH
Journal:  N Y State J Med       Date:  1953-12-15

4.  A new group of cycloplegic drugs.

Authors:  I H STOLZAR
Journal:  Am J Ophthalmol       Date:  1953-01       Impact factor: 5.258

  4 in total
  2 in total

1.  MYDRIASIS AND CYCLOPLEGIA.

Authors:  K D FOGGITT
Journal:  Br J Ophthalmol       Date:  1963-04       Impact factor: 4.638

2.  Refraction of 1-year-old children after cycloplegia with 1% cyclopentolate: comparison with findings after atropinisation.

Authors:  R M Ingram; A Barr
Journal:  Br J Ophthalmol       Date:  1979-05       Impact factor: 4.638

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.